Rhumatologie. Anti-TNF alpha: quels risques infectieux? Recommandations pratiques [Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations].


Autoria(s): Faucherre M.; Pazar B.; So A.; Aubry-Rozier B.
Data(s)

2011

Resumo

Anti-TNF alpha are immunomodulatory treatments prescribed for some rheumatologic inflammatory diseases (ex: spondylarthropathy, rheumatoid polyarthritis). The randomised studies suggested that anti-TNF alpha therapy is associated with an overall risk of infectious diseases. The results of the observational studies are more reassuring. In this article, we will describe some results of theses studies and propose some practical recommendations in use of the anti-TNF alpha therapy.

Identificador

http://serval.unil.ch/?id=serval:BIB_D6470C11F20E

isbn:1660-9379 (Print)

pmid:21309182

Idioma(s)

fr

Fonte

Revue Médicale Suisse, vol. 7, no. 277, pp. 75-6, 78-9

Palavras-Chave #Antirheumatic Agents/adverse effects; Bacterial Infections/etiology; Bacterial Infections/prevention & control; Humans; Opportunistic Infections/etiology; Opportunistic Infections/prevention & control; Rheumatic Diseases/drug therapy; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Tipo

info:eu-repo/semantics/review

article